Discovery of coding genetic variants influencing diabetes-related serum biomarkers and their impact on risk of type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Tarun Veer Singh Ahluwalia, Kristine Højgaard Allin, Camilla Helene Sandholt, Thomas Hempel Sparsø, Marit Eika Jørgensen, Michael Rowe, Cramer Christensen, Ivan Brandslund, Torsten Lauritzen, Allan Linneberg, Lise-Lotte Husemoen, Torben Jørgensen, Torben Hansen, Niels Grarup, Oluf Pedersen

CONTEXT: Type 2 diabetes (T2D) prevalence is spiraling globally, and knowledge of its pathophysiological signatures is crucial for a better understanding and treatment of the disease.

OBJECTIVE: We aimed to discover underlying coding genetic variants influencing fasting serum levels of nine biomarkers associated with T2D: adiponectin, C-reactive protein, ferritin, heat shock 70-kDa protein 1B, IGF binding protein 1 and IGF binding protein 2, IL-18, IL-2 receptor-α, and leptin.

DESIGN AND PARTICIPANTS: A population-based sample of 6215 adult Danes was genotyped for 16 340 coding single-nucleotide polymorphisms and were tested for association with each biomarker. Identified loci were tested for association with T2D through a large-scale meta-analysis involving up to 17 024 T2D cases and up to 64 186 controls.

RESULTS: We discovered 11 associations between single-nucleotide polymorphisms and five distinct biomarkers at a study-wide P < 3.4 × 10(-7). Nine associations were novel: IL18: BIRC6, RAD17, MARVELD2; ferritin: F5; IGF binding protein 1: SERPING1, KLKB, GCKR, CELSR2, and heat shock 70-kDa protein 1B: CFH. Three of the identified loci (CELSR2, HNF1A, and GCKR) were significantly associated with T2D, of which the association with the CELSR2 locus has not been shown previously.

CONCLUSION: The identified loci influence processes related to insulin signaling, cell communication, immune function, apoptosis, DNA repair, and oxidative stress, all of which could provide a rationale for novel diabetes therapeutic strategies.

Original languageEnglish
JournalThe Journal of clinical endocrinology and metabolism
Volume100
Issue number4
Pages (from-to)E664-71
ISSN0021-972X
DOIs
Publication statusPublished - Apr 2015

ID: 135494309